Skip Header

You are using a version of Internet Explorer that may not display all features of this website. Please upgrade to a modern browser.
Contribute Send feedback
Read comments (?) or add your own

O70161 (PI51C_MOUSE) Reviewed, UniProtKB/Swiss-Prot

Last modified July 9, 2014. Version 115. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma

Short name=PIP5K1-gamma
Short name=PtdIns(4)P-5-kinase 1 gamma
EC=2.7.1.68
Alternative name(s):
Phosphatidylinositol 4-phosphate 5-kinase type I gamma
Short name=PIP5KIgamma
Gene names
Name:Pip5k1c
Synonyms:Kiaa0589
OrganismMus musculus (Mouse) [Reference proteome]
Taxonomic identifier10090 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresGliresRodentiaSciurognathiMuroideaMuridaeMurinaeMusMus

Protein attributes

Sequence length661 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Catalyzes the phosphorylation of phosphatidylinositol 4-phosphate (PtdIns4P) to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). PtdIns(4,5)P2 is involved in a variety of cellular processes and is the substrate to form phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3), another second messenger. The majority of PtdIns(4,5)P2 is thought to occur via type I phosphatidylinositol 4-phosphate 5-kinases given the abundance of PtdIns4P. Participates in a variety of cellular processes such as vesicle mediated transport, cell adhesion, cell polarization and cell migration. Together with PIP5K1A is required for phagocytosis, but they regulate different types of actin remodeling at sequential steps. Promotes particle attachment by generating the pool of PtdIns(4,5)P2 that induces controlled actin depolymerization to facilitate Fc-gamma-R clustering. Mediates RAC1-dependent reorganization of actin filaments. Required for synaptic vesicle transport. Controls the plasma membrane pool of PtdIns(4,5)P2 implicated in synaptic vesicle endocytosis and exocytosis. Plays a role in endocytosis mediated by clathrin and AP-2 (adaptor protein complex 2). Required for clathrin-coated pits assembly at the synapse. Participates in cell junction assembly. Modulates adherens junctions formation by facilitating CDH1 trafficking. Required for focal adhesion dynamics. Modulates the targeting of talins (TLN1 and TLN2) to the plasma membrane and their efficient assembly into focal adhesions. Regulates the interaction between talins (TLN1 and TLN2) and beta-integrins. Required for uropodium formation and retraction of the cell rear during directed migration. Has a role in growth factor- stimulated directional cell migration and adhesion. Required for talin assembly into nascent adhesions forming at the leading edge toward the direction of the growth factor. Negative regulator of T-cell activation and adhesion. Negatively regulates integrin alpha-L/beta-2 (LFA-1) polarization and adhesion induced by T-cell receptor. Together with PIP5K1A have a role during embryogenesis and together with PIP5K1B may have a role immediately after birth. Ref.1 Ref.6 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.16 Ref.17 Ref.18

Catalytic activity

ATP + 1-phosphatidyl-1D-myo-inositol 4-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.

Enzyme regulation

Activated by phosphatidic acid. Ref.1

Subunit structure

Isoform 1 interacts with TLN1. Interacts with TLN2; interaction stimulates lipid kinase activity. May compete with beta-integrins for the same binding site on TLN1 and TLN2. Interacts with ARF6 By similarity. Interacts with AP2B1. Isoform 1 interacts with AP2M1; phosphorylation of PIP5K1C by CSK disrupts the interaction; clathrin competes with PIP5K1C. Interacts with CDH1 By similarity. Interacts with CSK. Interacts with PLCG1; interaction is abolished upon EGF stimulation. Ref.6 Ref.7 Ref.10 Ref.11 Ref.15

Subcellular location

Cell membrane; Peripheral membrane protein; Cytoplasmic side. Endomembrane system. Cytoplasm. Cell junctionfocal adhesion. Cell junctionadherens junction. Cell projectionruffle membrane. Cell projectionphagocytic cup. Cell projectionuropodium. Note: During directional migration isoform 1 localized at the uropodium, and isoform 3 localized all along cell membrane including the uropodium and the leading edge. Ref.6 Ref.7 Ref.12 Ref.16 Ref.17

Tissue specificity

High expression in brain. Also detected in lung, thymus, heart, testicle, kidney and embryo. Highly expressed in forebrain, in particular in cerebellum, hippocampus and cerebral cortex. Ref.1 Ref.8 Ref.17

Developmental stage

Expression increases during embryonic development and continued to steadily increase postnatally. Ref.17

Post-translational modification

Phosphorylation on Ser-645 negatively regulates binding to TLN2 and is strongly stimulated in mitosis. Phosphorylation on Tyr-644 is necessary for targeting to focal adhesions. Phosphorylation on Ser-645 and Tyr-644 are mutually exclusive. Phosphorylated by SYK and CSK. Tyrosine phosphorylation is enhanced by PTK2 signaling. Phosphorylated at Tyr-634 upon EGF stimulation. Some studies suggest that phosphorylation on Tyr-644 enhances binding to tailins (TLN1 and TLN2); others that phosphorylation at Tyr-644 does not directly enhance binding to tailins (TLN1 and TLN2) but may act indirectly by inhibiting phosphorylation at Ser-645. Ref.6 Ref.7 Ref.10 Ref.11 Ref.16

Acetylation at Lys-265 and Lys-268 seems to decrease lipid kinase activity. Deacetylation of these sites by SIRT1 positively regulates the exocytosis of TSH-containing granules from pituitary cells By similarity.

Disruption phenotype

According to some authors, mutants die within hours after birth and are unable to feed after birth (Ref.9). According to another report, mutants are embryonically lethal at organogenesis stage, and display cardiovascular and neuronal defects (Ref.9). PIP5K1C and PIP5K1B double mutant mice die within minutes after birth. PIP5K1C and PIP5K1A double mutant mice are embryonic lethal. Bone marrow-derived macrophages are defective in phagocytosis, attachment to IgG-opsonized particles and Fc-gamma-R clustering, and display highly polymerized actin cytoskeleton. Neurons display defects in synaptic transmission due to defects in synaptic vesicle trafficking at different levels. T-cells mutant for isoform 1 display increase adhesion and polarization. Ref.9 Ref.13 Ref.16 Ref.17 Ref.18

Sequence similarities

Contains 1 PIPK domain.

Biophysicochemical properties

Kinetic parameters:

KM=37 µM for PtdIns4P

KM=39 µM for ATP

Sequence caution

The sequence BAC65601.2 differs from that shown. Reason: Erroneous initiation.

Ontologies

Keywords
   Biological processCell adhesion
Chemotaxis
Endocytosis
Exocytosis
Phagocytosis
   Cellular componentCell junction
Cell membrane
Cell projection
Cytoplasm
Membrane
   Coding sequence diversityAlternative splicing
   LigandATP-binding
Nucleotide-binding
   Molecular functionKinase
Transferase
   PTMAcetylation
Phosphoprotein
   Technical term3D-structure
Complete proteome
Reference proteome
Gene Ontology (GO)
   Biological_processaxonogenesis

Inferred from direct assay Ref.8. Source: MGI

chemotaxis

Inferred from electronic annotation. Source: UniProtKB-KW

cytoskeletal anchoring at plasma membrane

Inferred from mutant phenotype PubMed 23372168. Source: MGI

exocytosis

Inferred from electronic annotation. Source: UniProtKB-KW

phagocytosis

Inferred from electronic annotation. Source: UniProtKB-KW

phosphatidylinositol metabolic process

Inferred from direct assay Ref.8Ref.1. Source: MGI

phosphatidylinositol phosphorylation

Inferred from direct assay Ref.8Ref.1. Source: GOC

platelet aggregation

Inferred from mutant phenotype PubMed 23372168. Source: MGI

   Cellular_componentcytoplasm

Inferred from electronic annotation. Source: UniProtKB-SubCell

endomembrane system

Inferred from electronic annotation. Source: UniProtKB-SubCell

focal adhesion

Inferred from electronic annotation. Source: UniProtKB-SubCell

phagocytic cup

Inferred from electronic annotation. Source: UniProtKB-SubCell

ruffle membrane

Inferred from electronic annotation. Source: UniProtKB-SubCell

uropod

Inferred from electronic annotation. Source: UniProtKB-SubCell

   Molecular_function1-phosphatidylinositol-4-phosphate 5-kinase activity

Inferred from direct assay Ref.8Ref.1. Source: MGI

ATP binding

Inferred from electronic annotation. Source: UniProtKB-KW

protein binding

Inferred from physical interaction PubMed 17290217. Source: IntAct

talin binding

Inferred from direct assay PubMed 23372168. Source: MGI

Complete GO annotation...

Binary interactions

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: O70161-1)

Also known as: PIPKIgamma661;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: O70161-2)

Also known as: PIPKIgamma627;

The sequence of this isoform differs from the canonical sequence as follows:
     343-402: Missing.
     635-635: F → FFAHGRYWLFSPRRRQLRAVTPNHTGT
Note: No experimental confirmation available.
Isoform 3 (identifier: O70161-3)

Also known as: PIPKIgamma635;

The sequence of this isoform differs from the canonical sequence as follows:
     636-661: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 661661Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma
PRO_0000185463

Regions

Domain75 – 443369PIPK
Region636 – 66126Mediates interaction with TLN2

Amino acid modifications

Modified residue2651N6-acetyllysine By similarity
Modified residue2681N6-acetyllysine By similarity
Modified residue6341Phosphotyrosine; by EGFR Ref.6 Ref.11
Modified residue6441Phosphotyrosine; by CSK Ref.6 Ref.7
Modified residue6451Phosphoserine; by CDK5, MAPK1 and CDK1 By similarity

Natural variations

Alternative sequence343 – 40260Missing in isoform 2.
VSP_016013
Alternative sequence6351F → FFAHGRYWLFSPRRRQLRAV TPNHTGT in isoform 2.
VSP_016014
Alternative sequence636 – 66126Missing in isoform 3.
VSP_016015

Experimental info

Mutagenesis2531D → A: Abolishes lipid kinase activity. Does not affect targeting of TLN1 to plasma membrane. Affects assembly of TLN1 into focal adhesions. Affects uropodium formation and retraction of the cell rear. Ref.6 Ref.12
Mutagenesis6341Y → F: Can not rescue the effect PIP5K1C knockdown on EGF-stimulated cell migration. Does not affect lipid kinase activity. Does not alter binding to tailin. Decreased tailin assembly into focal adhesions. Increased interaction with PLCG1. Ref.11
Mutagenesis6351F → A: Abolishes interaction with AP2B1. Ref.15
Mutagenesis6421W → A: Abolishes interaction with AP2B1. Ref.15
Mutagenesis6441Y → F: Loss of phosphorylation by CSK. Abolishes interaction with AP-2 complex. Can not rescue the effect PIP5K1C knockdown on EGF-stimulated cell migration. Ref.7 Ref.10 Ref.11 Ref.15
Mutagenesis6451S → F: Can not rescue the effect PIP5K1C knockdown on EGF-stimulated cell migration. Decreased tailin assembly into focal adhesions. Ref.11
Mutagenesis6461P → F: Abolishes interaction with AP-2 complex. Ref.10
Mutagenesis6471L → V: Abolishes interaction with AP-2 complex. Ref.10
Sequence conflict1101V → M in BAA25664. Ref.1
Sequence conflict1221L → F in BAA25664. Ref.1

Secondary structure

..... 661
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (PIPKIgamma661) [UniParc].

Last modified October 25, 2005. Version 2.
Checksum: 4A3B71E4465B83C3

FASTA66172,408
        10         20         30         40         50         60 
MELEVPDEAE SAEAGAVTAE AAWSAESGAA AGMTQKKAGL AEAPLVTGQP GPGHGKKLGH 

        70         80         90        100        110        120 
RGVDASGETT YKKTTSSTLK GAIQLGIGYT VGNLSSKPER DVLMQDFYVV ESIFFPSEGS 

       130        140        150        160        170        180 
NLTPAHHFQD FRFKTYAPVA FRYFRELFGI RPDDYLYSLC NEPLIELSNP GASGSVFYVT 

       190        200        210        220        230        240 
SDDEFIIKTV MHKEAEFLQK LLPGYYMNLN QNPRTLLPKF YGLYCVQSGG KNIRVVVMNN 

       250        260        270        280        290        300 
VLPRVVKMHL KFDLKGSTYK RRASKKEKEK SLPTYKDLDF MQDMPEGLLL DSDTFGALVK 

       310        320        330        340        350        360 
TLQRDCLVLE SFKIMDYSLL LGVHNIDQQE RERQAEGAQS KADEKRPVAQ KALYSTAMES 

       370        380        390        400        410        420 
IQGGAARGEA IETDDTMGGI PAVNGRGERL LLHIGIIDIL QSYRFIKKLE HTWKALVHDG 

       430        440        450        460        470        480 
DTVSVHRPSF YAERFFKFMS STVFRKSSSL KSSPSKKGRG ALLAVKPLGP TAAFSASQIP 

       490        500        510        520        530        540 
SEREDVQYDL RGARSYPTLE DEGRPDLLPC TPPSFEEATT ASIATTLSST SLSIPERSPS 

       550        560        570        580        590        600 
DTSEQPRYRR RTQSSGQDGR PQEEPHAEDL QKITVQVEPV CGVGVVPKEE GAGVEVPPCG 

       610        620        630        640        650        660 
ASAAASVEID AASQASEPAS QASDEEDAPS TDIYFPTDER SWVYSPLHYS ARPASDGESD 


T 

« Hide

Isoform 2 (PIPKIgamma627) [UniParc].

Checksum: C40D860D3F3419BD
Show »

FASTA62769,199
Isoform 3 (PIPKIgamma635) [UniParc].

Checksum: 781F012CC868250A
Show »

FASTA63569,502

References

« Hide 'large scale' references
[1]"Type I phosphatidylinositol-4-phosphate 5-kinases. Cloning of the third isoform and deletion/substitution analysis of members of this novel lipid kinase family."
Ishihara H., Shibasaki Y., Kizuki N., Wada T., Yazaki Y., Asano T., Oka Y.
J. Biol. Chem. 273:8741-8748(1998) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION, ALTERNATIVE SPLICING, TISSUE SPECIFICITY.
[2]"Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries."
Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S., Nakajima D., Nagase T., Ohara O., Koga H.
DNA Res. 10:35-48(2003) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
Tissue: Fetal brain.
[3]Okazaki N., Kikuno R., Nagase T., Ohara O., Koga H.
Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases
Cited for: SEQUENCE REVISION.
[4]"The transcriptional landscape of the mammalian genome."
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. expand/collapse author list , Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.
Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
Strain: C57BL/6J and NOD.
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
Strain: FVB/N.
Tissue: Brain and Kidney.
[6]"Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions."
Ling K., Doughman R.L., Firestone A.J., Bunce M.W., Anderson R.A.
Nature 420:89-93(2002) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN FOCAL ADHESION DYNAMIC, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYROSINE RESIDUES, INTERACTION WITH TLN1, MUTAGENESIS OF ASP-253.
[7]"Tyrosine phosphorylation of type Igamma phosphatidylinositol phosphate kinase by Src regulates an integrin-talin switch."
Ling K., Doughman R.L., Iyer V.V., Firestone A.J., Bairstow S.F., Mosher D.F., Schaller M.D., Anderson R.A.
J. Cell Biol. 163:1339-1349(2003) [PubMed] [Europe PMC] [Abstract]
Cited for: INTERACTION WITH TLN1, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-644, MUTAGENESIS OF TYR-644.
[8]"A novel neuronal-specific splice variant of Type I phosphatidylinositol 4-phosphate 5-kinase isoform gamma."
Giudici M.-L., Emson P.C., Irvine R.F.
Biochem. J. 379:489-496(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: TISSUE SPECIFICITY.
[9]"Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking."
Di Paolo G., Moskowitz H.S., Gipson K., Wenk M.R., Voronov S., Obayashi M., Flavell R., Fitzsimonds R.M., Ryan T.A., De Camilli P.
Nature 431:415-422(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN SYNAPTIC VESICLE TRAFFICKING, DISRUPTION PHENOTYPE.
[10]"Type Igamma661 phosphatidylinositol phosphate kinase directly interacts with AP2 and regulates endocytosis."
Bairstow S.F., Ling K., Su X., Firestone A.J., Carbonara C., Anderson R.A.
J. Biol. Chem. 281:20632-20642(2006) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN CLATHRIN-MEDIATED ENDOCYTOSIS, INTERACTION WITH AP2M1 AND TLN1, PHOSPHORYLATION, MUTAGENESIS OF TYR-644; PRO-646 AND LEU-647.
[11]"Type I gamma phosphatidylinositol phosphate kinase is required for EGF-stimulated directional cell migration."
Sun Y., Ling K., Wagoner M.P., Anderson R.A.
J. Cell Biol. 178:297-308(2007) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN CELL MIGRATION AND ADHESION, INTERACTION WITH PLCG1, PHOSPHORYLATION AT TYR-634, MUTAGENESIS OF TYR-634; TYR-644 AND SER-645.
[12]"Type Igamma PIP kinase is a novel uropod component that regulates rear retraction during neutrophil chemotaxis."
Lokuta M.A., Senetar M.A., Bennin D.A., Nuzzi P.A., Chan K.T., Ott V.L., Huttenlocher A.
Mol. Biol. Cell 18:5069-5080(2007) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN NEUTROPHIL CHEMOTAXIS, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-253.
[13]"PIP5KI gamma is required for cardiovascular and neuronal development."
Wang Y., Lian L., Golden J.A., Morrisey E.E., Abrams C.S.
Proc. Natl. Acad. Sci. U.S.A. 104:11748-11753(2007) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN EMBRYOGENESIS, DISRUPTION PHENOTYPE.
[14]"The phagosomal proteome in interferon-gamma-activated macrophages."
Trost M., English L., Lemieux S., Courcelles M., Desjardins M., Thibault P.
Immunity 30:143-154(2009) [PubMed] [Europe PMC] [Abstract]
Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
[15]"Clathrin regulates the association of PIPKIgamma661 with the AP-2 adaptor beta2 appendage."
Thieman J.R., Mishra S.K., Ling K., Doray B., Anderson R.A., Traub L.M.
J. Biol. Chem. 284:13924-13939(2009) [PubMed] [Europe PMC] [Abstract]
Cited for: INTERACTION WITH AP2B1, MUTAGENESIS OF PHE-635; TRP-642 AND TYR-644.
[16]"Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis."
Mao Y.S., Yamaga M., Zhu X., Wei Y., Sun H.-Q., Wang J., Yun M., Wang Y., Di Paolo G., Bennett M., Mellman I., Abrams C.S., De Camilli P., Lu C.Y., Yin H.L.
J. Cell Biol. 184:281-296(2009) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN PHAGOCYTOSIS, SUBCELLULAR LOCATION, PHOSPHORYLATION, DISRUPTION PHENOTYPE.
[17]"Phosphatidylinositol-4-phosphate 5-kinases and phosphatidylinositol 4,5-bisphosphate synthesis in the brain."
Volpicelli-Daley L.A., Lucast L., Gong L.-W., Liu L., Sasaki J., Sasaki T., Abrams C.S., Kanaho Y., De Camilli P.
J. Biol. Chem. 285:28708-28714(2010) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN EMBRYOGENESIS, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE.
[18]"PIPKI gamma 90 negatively regulates LFA-1-mediated adhesion and activation in antigen-induced CD4+ T cells."
Wernimont S.A., Legate K.R., Simonson W.T.N., Fassler R., Huttenlocher A.
J. Immunol. 185:4714-4723(2010) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION IN CELL ADHESION, DISRUPTION PHENOTYPE.
[19]"Structural basis for phosphatidylinositol phosphate kinase type Igamma binding to talin at focal adhesions."
de Pereda J.M., Wegener K.L., Santelli E., Bate N., Ginsberg M.H., Critchley D.R., Campbell I.D., Liddington R.C.
J. Biol. Chem. 280:8381-8386(2005) [PubMed] [Europe PMC] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 636-652 IN COMPLEX WITH TLN1.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AB006916 mRNA. Translation: BAA25664.1.
AK122319 mRNA. Translation: BAC65601.2. Different initiation.
AK154816 mRNA. Translation: BAE32849.1.
AK171576 mRNA. Translation: BAE42536.1.
BC019138 mRNA. Translation: AAH19138.1.
BC094665 mRNA. Translation: AAH94665.1.
CCDSCCDS35994.1. [O70161-1]
CCDS48643.1. [O70161-3]
RefSeqNP_001140159.1. NM_001146687.1. [O70161-3]
NP_032870.2. NM_008844.2. [O70161-1]
XP_006513436.1. XM_006513373.1.
UniGeneMm.29836.
Mm.471109.

3D structure databases

PDBe
RCSB-PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1Y19X-ray2.60A/C/E/G/I/K638-651[»]
2H7DNMR-B643-652[»]
2H7ENMR-B643-652[»]
ProteinModelPortalO70161.
SMRO70161. Positions 76-328.
ModBaseSearch...
MobiDBSearch...

Protein-protein interaction databases

IntActO70161. 8 interactions.
MINTMINT-4105231.

PTM databases

PhosphoSiteO70161.

Proteomic databases

MaxQBO70161.
PaxDbO70161.
PRIDEO70161.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENSMUST00000105327; ENSMUSP00000100964; ENSMUSG00000034902. [O70161-1]
ENSMUST00000163075; ENSMUSP00000124155; ENSMUSG00000034902. [O70161-3]
GeneID18717.
KEGGmmu:18717.
UCSCuc007ghc.2. mouse. [O70161-1]

Organism-specific databases

CTD23396.
MGIMGI:1298224. Pip5k1c.
RougeSearch...

Phylogenomic databases

eggNOGCOG5253.
GeneTreeENSGT00690000101870.
HOGENOMHOG000193876.
HOVERGENHBG052818.
InParanoidO70161.
KOK00889.
OrthoDBEOG70W3DM.
PhylomeDBO70161.
TreeFamTF319618.

Gene expression databases

ArrayExpressO70161.
BgeeO70161.
GenevestigatorO70161.

Family and domain databases

Gene3D3.30.800.10. 1 hit.
3.30.810.10. 1 hit.
InterProIPR023610. PInositol-4-P-5-kinase.
IPR027483. PInositol-4-P-5-kinase_C.
IPR002498. PInositol-4-P-5-kinase_core.
IPR027484. PInositol-4-P-5-kinase_N.
IPR016034. PInositol-4P-5-kinase_core_sub.
[Graphical view]
PANTHERPTHR23086. PTHR23086. 1 hit.
PfamPF01504. PIP5K. 1 hit.
[Graphical view]
SMARTSM00330. PIPKc. 1 hit.
[Graphical view]
PROSITEPS51455. PIPK. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

ChiTaRSPIP5K1C. mouse.
EvolutionaryTraceO70161.
NextBio294809.
PROO70161.
SOURCESearch...

Entry information

Entry namePI51C_MOUSE
AccessionPrimary (citable) accession number: O70161
Secondary accession number(s): Q505A1, Q80TW9, Q8VCU5
Entry history
Integrated into UniProtKB/Swiss-Prot: October 25, 2005
Last sequence update: October 25, 2005
Last modified: July 9, 2014
This is version 115 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program

Relevant documents

SIMILARITY comments

Index of protein domains and families

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

MGD cross-references

Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot